Literature DB >> 9074508

Human gene encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase): organization, nucleotide sequence and alternative splicing.

K Nata1, T Takamura, T Karasawa, T Kumagai, W Hashioka, A Tohgo, H Yonekura, S Takasawa, S Nakamura, H Okamoto.   

Abstract

We have recently demonstrated that cyclic ADP-ribose (cADPR) serves as a second messenger for glucose-induced insulin secretion [Takasawa et al. (1993a) Science 259, 370-373] and that CD38 has both ADP-ribosyl cyclase (ADRC) and cADPR hydrolase activities [Takasawa et al. (1993b) J. Biol. Chem. 268, 26052-26054]. In this study, we determined the structure of the human CD38 gene, and showed that two mRNA forms originated by alternative splicing from the CD38 gene. The human CD38 gene consists of 8 exons that extend more than 77 kb on the human genome. Exon 1 encoded the 5'-untranslated region of the mRNA, the N-terminal end of CD38 and the putative transmembrane domain, and exon 2-8 encoded the remainder of CD38: the exon-intron organization of the human CD38 gene is similar to that of the Aplysia ADRC gene [Nata et al. (1995) Gene 158, 213-218]. This structural conservation between human and Aplysia genes suggests that both genes may have evolved from a common ancestral gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9074508     DOI: 10.1016/s0378-1119(96)00723-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  17 in total

1.  Novel peptide inhibitor of ecto-ADP-ribosyl cyclase of bone marrow stromal cell antigen-1 (BST-1/CD157).

Authors:  A Sato; S Yamamoto; K Ishihara; T Hirano; H Jingami
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

2.  Identification of a major enzyme for the synthesis and hydrolysis of cyclic ADP-ribose in amphibian cells and evolutional conservation of the enzyme from human to invertebrate.

Authors:  Takayuki Ikeda; Shin Takasawa; Naoya Noguchi; Koji Nata; Akiyo Yamauchi; Iwao Takahashi; Takeo Yoshikawa; Akira Sugawara; Hideto Yonekura; Hiroshi Okamoto
Journal:  Mol Cell Biochem       Date:  2012-03-16       Impact factor: 3.396

3.  CD38-dependent ADP-ribosyl cyclase activity in developing and adult mouse brain.

Authors:  Claire Ceni; Nathalie Pochon; Virginie Brun; Hélène Muller-Steffner; Annie Andrieux; Didier Grunwald; Francis Schuber; Michel De Waard; Frances Lund; Michel Villaz; Marie-Jo Moutin
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

4.  CD38 and E2F transcription factor 2 have uniquely increased expression in rheumatoid arthritis synovial tissues.

Authors:  X Chang; L Yue; W Liu; Y Wang; L Wang; B Xu; Y Wang; J Pan; X Yan
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

5.  The CD38-cyclic ADP-ribose signaling system in insulin secretion.

Authors:  H Okamoto
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

6.  CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools.

Authors:  Jeffrey P Chmielewski; Sarah C Bowlby; Frances B Wheeler; Lihong Shi; Guangchao Sui; Amanda L Davis; Timothy D Howard; Ralph B D'Agostino; Lance D Miller; S Joseph Sirintrapun; Scott D Cramer; Steven J Kridel
Journal:  Mol Cancer Res       Date:  2018-08-03       Impact factor: 5.852

Review 7.  Anti-CD38 autoantibodies in type? diabetes.

Authors:  Roberto Mallone; Paolo Cavallo Perin
Journal:  Diabetes Metab Res Rev       Date:  2006 Jul-Aug       Impact factor: 4.876

8.  Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin- dependent diabetes patients.

Authors:  F Ikehata; J Satoh; K Nata; A Tohgo; T Nakazawa; I Kato; S Kobayashi; T Akiyama; S Takasawa; T Toyota; H Okamoto
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

9.  The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymes.

Authors:  Silvia Deaglio; Fabio Malavasi
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

10.  Characterization of a CD38-like 78-kilodalton soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia.

Authors:  R Mallone; S Ferrua; M Morra; E Zocchi; K Mehta; L D Notarangelo; F Malavasi
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.